Effect of 180 mgTicagrelor Compared With 90 mg Ticagrelor on Platelet Reactivity in Patients Undergoing Elective PCI.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Ticagrelor (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 21 Jul 2015 Planned End Date changed from 1 Jan 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
- 21 Jul 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Dec 2015, according to ClinicalTrials.gov record.
- 30 Jul 2014 New trial record